Skip to content

What women need to know about prostate cancer

What women need to know about prostate cancer

Prostate cancer is not a womans disease. However, chances are that one of your loved ones (partner, father, brother) may be affected by prostate cancer at some point in his life. While 50 percent of prostate cancer cases occur in men over the age of 65, it can affect younger men as well. The following…

Read more

British Prime Minister pledges £75m for prostate cancer

Clinical_research

The announcement of a major investment in prostate cancer research was covered widely by the British media today. The announcement is covered in the Financial Times and The Guardian newspaper. The main points that were made are: Prostate Cancer kills 11,000 men in the UK every year. Recent statistics showed that Prostate Cancer overtook breast…

Read more

MRI for a more accurate prostate cancer assessment

This article which was published by the American College of Radiology, explains how Dr. Ross Schwartzberg is pioneering the use of MRI for the assessment of prostate cancer in San Diego. The main points in the article are: PSA is the established traditional screening method for prostate cancer. We now know that MRI provides a…

Read more

MRI -A whole new look at prostate cancer

This is a video presentation, given by DR Ross Schwartzberg MD to other doctors and medical students in Merci Hospital San Diego: The presentation focusses on the importance of using MRI to detect prostate cancer. The main points in his video presentation are: The Benefits of using MRI in prostate cancer MRI used as a…

Read more

Prostate cancer deaths now overtake breast cancer

The number of men dying from prostate cancer in Great Britain is higher than the number of women dying from breast cancer – says the newest study from Prostate Cancer UK. After lung and bowel cancer, prostate cancer has now become the third most lethal type of cancer. Prostate Cancer UK’s most recent evaluation has…

Read more

Impressive results for treatment of PCa recurrent disease with NanoKnife Therapy

No incontinence and no negative change in erectile function in prostate cancer patients with recurrent disease Can patients with returning prostate cancer get treatment without fear of incontinence and erectile dysfunction? A novel study shows they can: The Vitus Prostate Center presented data on recurrent disease at the Annual Meeting of the Radiological Society of…

Read more

Treating advanced prostate cancer with focal therapy

The effective and gentle therapy of prostate cancer with infiltration of the urinary sphincter may soon become more than wishful thinking. In his newest scientific publication, Prof. Stehling and his medical and scientific team have demonstrated the effective treatment of locally advanced, high-risk prostate cancer with focal therapy. In this case report, which was published…

Read more

One in five men is affected by prostate cancer

At Vitus Prostate Center we always keep our finger on the pulse of the latest developments, thanks to the close co-operation of our medical doctors and physicists with universities and industry both in Germany and abroad. This is how we managed to establish ourselves as the leaders in NanoKnife®(IRE)-therapy of prostate cancer. Besides our clinical…

Read more

Participation in Multi-Center Register Study for IRE

Medical doctors and scientists at the Vitus Prostate Center in Frankfurt/Offenbach have been using Irreversible Electroporation (IRE; product name: NanoKnife®) for the treatment of prostate cancer in about 600 cases over the last 7 years. In close collaboration with the inventor of the IRE-technology, Prof. Boris Rubinsky from the University of California in Berkeley, the…

Read more